Global Testosterone Therapy Market: Trends and Opportunities (2013-2018)
Description-
Executive
Summary
Testosterone
Therapy
is a process of giving testosterone when the human body does not
produce sufficient amount of testosterone because of old age, injury,
damage or absence. Male hypogonadism means the testicles don\'t
produce enough of the male sex hormone testosterone; this is when
testosterone replacement therapy (TRT) is used as a solution. TRT has
gained momentum in the last decade with increase in the number of
cases of hypogonadism.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-testosterone-therapy-market-trends-and-opportunities-2013-2018-report.html
The
sales of testosterone products have increased globally and it is
expected to increase even further in coming years. The U.S is the
main market for TRT with the highest penetration rate and
characterized by the presence of all the major market players
including AbbVie, Eli Lilly, Auxillium Pharmaceuticals and Actavis.
Low penetration rate of testosterone replacement therapy in the
geographical regions of Europe and Asia-Pacific is because of the
fact that this is a lesser known technology. But nevertheless, low
penetration and higher need for this treatment results in a largely
untapped market that needs strong promotional activities and
awareness programs.
New
Products such as Axiron, AndroGel 1.62% and Foresta, which were
introduced recently in the market are slowly replacing old brands and
are gaining market share. Gels are becoming the dominant segment of
testosterone deficiency treatment and are replacing injectables,
orals and patches segments.
Scope
of the Report
The
report titled “Global Testosterone Therapy Market”: Trends &
Opportunities (2013-2018)” provides an in-depth analysis of the
global Testosterone Therapy market with detailed analysis of
symptoms, diagnosis and treatment of testosterone deficiency. The
report majorly focuses on the US testosterone therapy market and also
assesses the key opportunities in the market and outlines the factors
that are and will be driving the growth of the industry. Growth of
the overall testosterone therapy industry has also been forecasted
for the period 2013-2018, taking into consideration the previous
growth patterns, the growth drivers and the current and future
trends. Further, key players of the industry like AbbVie Inc, Actavis
Inc, Eli Lilly & Co. and Auxilium Pharmaceuticals Inc are
profiled.
Company
Coverage
AbbVie
Inc
Actavis
Inc
Eli
Lilly & Co.
Auxilium
Pharmaceuticals Inc
Table
of Content
1.
Executive Summary
2.
Low Testosterone: Causes and Treatment
2.1
Causes of Low Testosterone
2.2
Symptoms of Low Testosterone
2.3
Low Testosterone Detection
2.4
Hypogonadism
2.4.1
Classification of Hypogonadism
2.5
Testosterone Deficiency with Ageing
2.6
Treatments of Low Testosterone
2.6.1
Transdermal
2.6.2
Sublingual/Buccal
2.6.3
Subcutaneous Pellet
2.6.4
Injectable
2.6.5
Oral
2.7
Benefits of Testosterone Replacement Therapy
2.8
Risks of Testosterone Replacement Therapy
3.
Global Testosterone Therapy Market: An Analysis
3.1
Market Sizing and Growth
3.2
Market Share of Testosterone Products
3.3
Global Testosterone Replacement Therapy Treatment Penetration
3.4
Distribution of Testosterone Therapy Options
3.5
Global Hypogonadism Market Size and Forecast
3.6
Number of patients Treated Globally by Hypogonadism and Forecast
4.
The U.S Testosterone Therapy Market: An Analysis
4.1
Market Sizing and Growth: Actual and Forecast
4.2
The U.S Testosterone Products Sales
4.3
The U.S Market Share for Transdermal Products
4.4
The U.S and Ex-U.S Testosterone Therapy Share
4.5
The U.S Hypogonadism Market Size and Forecast
4.6
Number of Patients Treated in the U.S for Hypogonadism and Forecast
4.7
The U.S and Ex-U.S Hypogonadism Treatment Penetration
5.
Testosterone Therapy Market: Competitive Landscape
5.1
Testosterone Products Produced by Leading Companies
5.2
Revnue by Product
5.3
Annual Sales Growth of Companies
6.
Testosterone Therapy: Market Dynamics
6.1
Challenges of Testosterone Therapy Market
6.2
Growth Drivers
6.3
Market Trends
6.3.1
New Product Portfolio
6.3.2
New Methods of TRT
6.3.3
Testosterone Therapy for Women
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment